Physician profile
Lee Forestiere
NPI 1447216270
$598.21
in general payments reported to CMS, 2019-2025
17 companies · $64.83 in 2025
The $64.83 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.42 · 2020: $42.53 · 2021: $194 · 2022: $114 · 2023: $62.66 · 2024: $46.20 · 2025: $64.83.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $173.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $92.36 | 2021-2025 | |
| Ethicon US, LLC | $71.80 | 2020-2021 | |
| Innocoll Pharmaceuticals Limited | $53.05 | 2021-2022 | |
| Becton, Dickinson and Company | $43.59 | 2022 | |
| Smith+Nephew, INC. | $37.45 | 2025 | Stravix |
| Allergan, INC. | $37.17 | 2020-2021 | |
| Convatec INC. | $36.61 | 2023-2024 | |
| Kci USA, INC. | $32.83 | 2021-2023 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Ge Healthcare | $32.04 | 2024 | |
| Intuitive Surgical, INC. | $29.39 | 2019 | |
| Z-Medica, LLC | $29.37 | 2019 | |
| Baudax Bio INC. | $24.90 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.14 | 2021 | |
| Covidien LP | $15.66 | 2019 | |
| Teleflex LLC | $15.19 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $14.74 | 2020 | |
| Acera Surgical, INC. | $11.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lee Forestiere listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.